INHBE-3

Intervention

1 paper4 findings

  • 1 lab
  • Animals1

Outcomes

4

Fibrosis

downin mice1−58%

1 study
  1. INHBE-3 decreases fibrosis in mice (-58%).

    “reductions in total (41%) and pro-inflammatory (80%) macrophages and fibrosis (58%) were observed in visceral fat.”

    Animalsdiet-induced obesityGalNAc-conjugated siRNAvisceral fat56 days

    Silencing Hepatokine Activin E Promotes a Healthy Body Composition and Metabolic Profile in Mice

    ADA Scientific Sessions 2026 abstract5 Jun 2026

Muscle mass

no changein mice1

1 study
  1. INHBE-3 has no effect on muscle mass in mice.

    “There was no statistically significant change in quadricep muscle mass.”

    Animalsdiet-induced obesityGalNAc-conjugated siRNAquadricep muscle28 days

    Silencing Hepatokine Activin E Promotes a Healthy Body Composition and Metabolic Profile in Mice

    ADA Scientific Sessions 2026 abstract5 Jun 2026

Visceral fat mass

downin mice1−40%

1 study
  1. INHBE-3 decreases visceral fat mass in mice (-40%).

    “with a 40% reduction in visceral fat mass and 43% less adipocyte hypertrophy.”

    Animalsdiet-induced obesityGalNAc-conjugated siRNAvisceral fat28 days

    Silencing Hepatokine Activin E Promotes a Healthy Body Composition and Metabolic Profile in Mice

    ADA Scientific Sessions 2026 abstract5 Jun 2026

Body weight

downin mice1−9%

1 study
  1. INHBE-3 decreases body weight in mice (-9%).

    “At day 28, INHBE-3 treated mice weighed 9% less than controls, with a 40% reduction in visceral fat mass and 43% less adipocyte hypertrophy.”

    Animalsdiet-induced obesityGalNAc-conjugated siRNA28 days

    Silencing Hepatokine Activin E Promotes a Healthy Body Composition and Metabolic Profile in Mice

    ADA Scientific Sessions 2026 abstract5 Jun 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months